Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Removing Blood Stasis Therapy in Acute Cerebral Hemorrhage
NCT03354026Phase 4Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Nov 2017
- Primary completion
- Dec 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 4, randomised trial of ICH-1 in intracerebral hemorrhage (ICH) (3 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Rate of enlargement of brain hematoma. Status: unknown.
02
Drugs
ICH-1
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03354026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354026.